Zinc Carnosine 用于 肠道通透性增加(肠漏)
C 证据 来自小型研究的证据有限,但存在一些积极信号。Reduces NSAID-induced permeability increase. Small study sizes limit conclusions.
结论
Reduces NSAID-induced permeability increase. Small study sizes limit conclusions.
Key Study Findings
研究人群: Healthy volunteers during heavy exercise
Key Statistics
2
研究数量
100
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 75 mg twice daily (as zinc carnosine complex)
- nsaidprotection:
- 37.5-75 mg twice daily alongside NSAID therapy
- gastricprotection:
- 75 mg twice daily for 8 weeks
上限: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| zinc carnosine 37.5 mg + bovine colostrum 10g bid | 2 weeks | Positive | 8 |
最佳服用时间: On an empty stomach or between meals for gastric mucosal contact; twice daily
Safety & Side Effects
已报告的副作用
- ⚠ Nausea (most common, usually transient)
- ⚠ Metallic taste
- ⚠ Copper depletion with long-term high-dose use (>40 mg elemental zinc/day)
- ⚠ Headache
已知相互作用
- ● Tetracycline and quinolone antibiotics (zinc reduces absorption; space 2 hours)
- ● Penicillamine (zinc reduces absorption)
- ● Copper supplements (zinc competes with copper for absorption)
- ● Bisphosphonates (zinc may reduce absorption; space 2 hours)
可耐受最高摄入量: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Zinc Carnosine help with 肠道通透性增加(肠漏)?
How much Zinc Carnosine should I take for 肠道通透性增加(肠漏)?
Are there side effects of Zinc Carnosine?
How strong is the evidence for Zinc Carnosine and 肠道通透性增加(肠漏)?
Related Evidence
其他成分用于 肠道通透性增加(肠漏)
Zinc Carnosine 用于其他健康状况
References
- [1] Glen Davison et al.. Am J Clin Nutr. 2016. Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers. doi:10.3945/ajcn.116.134403 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。